BMO
DXCM icon

Beck Mack & Oliver’s DexCom DXCM Stock Holding History

Beck Mack & Oliver’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,818
Closed -$206K – 176
2024
Q2 		$206K Hold
1,818
– – ﹤0.01% 168
2024
Q1 		$252K Hold
1,818
– – 0.01% 153
2023
Q4 		$226K Buy
+1,818
New +$186K 0.01% 165

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Beck Mack & Oliver's DXCM Position: Q3 2024 in Review

Beck Mack & Oliver sold out of DexCom (DXCM) in Q3 2024, closing a stake of 1,818 shares — an estimated $206K sold.

Beck Mack & Oliver first reported a position in DXCM in Q4 2023 and held it in 3 quarters. The position peaked at $252K in Q1 2024. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Beck Mack & Oliver reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Beck Mack & Oliver sold 1,818 DexCom shares in Q3 2024, an estimated $206K.
  • Beck Mack & Oliver first reported a position in DexCom in Q4 2023 and held it in 3 quarters.
  • Beck Mack & Oliver's DexCom position peaked at $252K in Q1 2024.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Beck Mack & Oliver's 13F filing for Q3 2024, filed 13 Nov 2024.